![David Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Moore
Directeur/Membre du Conseil chez
CORIUM INTERNATIONAL INC
Fortune : 324 198 $ au 30/06/2026
Profil
David S.
Moore is Chairman at Novasenta, Inc. since 2023.
Holds director positions at Corium LLC (Massachusetts) and Tremeau Pharmaceuticals, Inc. Serves as Independent Director at Corvus Pharmaceuticals, Inc. starting 2025.
Senior Vice President-US Commercial at Novo Nordisk, Inc. since 2017.
Partner at Gurnet Point Capital LLC since 2020.
Former Chief Executive Officer at Roivant Sciences, Inc. from 2019 to 2020.
Independent Director at Sirona Biochem Corp.
from 2014 to 2017.
Director at Alladapt Immunotherapeutics, Inc. President & Chief Commercial Officer at Cempra, Inc. from 2016 to 2019.
Chief Business Officer at OCERA Therapeutics LLC in 2013.
Chief Business Officer at Tranzyme Pharma, Inc. (Canada) from 2012 to 2013.
Education includes undergraduate studies at Thomas Jefferson University and Towson University, and an MBA from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 21 700 ( 0,03 % ) | 324 198 $ | 30/06/2026 |
Postes actifs de David Moore
| Sociétés | Poste | Début |
|---|---|---|
| CORIUM INTERNATIONAL INC | Directeur/Membre du Conseil | - |
| CORVUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/10/2025 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Private Equity Investor | 01/03/2020 |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Directeur/Membre du Conseil | - |
Novasenta, Inc.
 Novasenta, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for immune-mediated diseases and cancer | Président | 01/01/2023 |
Anciens postes connus de David Moore
| Sociétés | Poste | Fin |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Directeur Général | 01/03/2020 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | President | 01/05/2019 |
| SIRONA BIOCHEM CORP. | Directeur/Membre du Conseil | 27/10/2017 |
| OCERA THERAPEUTICS INC | Corporate Officer/Principal | 01/07/2013 |
| ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Moore
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sirona Biochem Corp.
 Sirona Biochem Corp. Pharmaceuticals: MajorHealth Technology Develops cosmetic and pharmaceutical active ingredients | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Towson University
 Towson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Tranzyme Pharma, Inc. (Canada) | |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Health Technology |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics targeting food allergy | Health Technology |
Novasenta, Inc.
Novasenta, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for immune-mediated diseases and cancer | Health Technology |
